These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6338806)

  • 41. Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis.
    Johnson RH; Hornabrook RW; Lambie DG
    Acta Neurol Scand; 1986 May; 73(5):490-2. PubMed ID: 3524092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine.
    Stensrud P; Sjaastad O
    Ups J Med Sci Suppl; 1980; 31():37-40. PubMed ID: 7006182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.
    Dodick DW; Lipton RB; Goadsby PJ; Tfelt-Hansen P; Ferrari MD; Diener HC; Almas M; Albert KS; Parsons B
    Headache; 2008 Feb; 48(2):184-93. PubMed ID: 18234045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Duration of migraine is a predictor for response to botulinum toxin type A.
    Eross EJ; Gladstone JP; Lewis S; Rogers R; Dodick DW
    Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Propranolol in the treatment of migraine.
    Wideroe TE; Vigander T
    Br Med J; 1974 Jun; 2(5921):699-701. PubMed ID: 4604977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of propranolol and pregabalin for prophylaxis of childhood migraine: a randomised controlled trial.
    Bakhshandeh Bali M; Rahbarimanesh AA; Sadeghi M; Sedighi M; Karimzadeh P; Ghofrani M
    Acta Med Iran; 2015; 53(5):276-80. PubMed ID: 26024701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acupuncture in migraine prevention: a randomized sham controlled study with 6-months posttreatment follow-up.
    Alecrim-Andrade J; Maciel-Júnior JA; Carnè X; Severino Vasconcelos GM; Correa-Filho HR
    Clin J Pain; 2008 Feb; 24(2):98-105. PubMed ID: 18209514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Use of propranolol for migraine prophylaxis].
    Tfelt-Hansen P
    Ugeskr Laeger; 2005 Mar; 167(10):1181-3. PubMed ID: 15810579
    [No Abstract]   [Full Text] [Related]  

  • 49. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
    Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Flunarizine for prophylactic treatment of childhood migraine.
    Visudtibhan A; Lusawat A; Chiemchanya S; Visudhiphan P
    J Med Assoc Thai; 2004 Dec; 87(12):1466-70. PubMed ID: 15822542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Propranolol and femoxetine, a HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study.
    Andersson PG; Petersen EN
    Acta Neurol Scand; 1981 Oct; 64(4):280-8. PubMed ID: 7032183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug interaction--propranolol and cafergot.
    Baumrucker JF
    N Engl J Med; 1973 Apr; 288(17):916-7. PubMed ID: 4693950
    [No Abstract]   [Full Text] [Related]  

  • 53. Long-acting propranolol in the prophylaxis of migraine: a comparative study of two doses.
    Carroll JD; Reidy M; Savundra PA; Cleave N; McAinsh J
    Cephalalgia; 1990 Apr; 10(2):101-5. PubMed ID: 2193712
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Migraine in the child. Clinical study of 212 patients].
    Calderón-González R; Sevilla-Castillo R; Carrera-Sandoval JP; Vallejo-Moreno D
    Bol Med Hosp Infant Mex; 1988 Oct; 45(10):637-44. PubMed ID: 3264170
    [No Abstract]   [Full Text] [Related]  

  • 55. Propranolol in acute migraine: a controlled study.
    Fuller GN; Guiloff RJ
    Cephalalgia; 1990 Oct; 10(5):229-33. PubMed ID: 2272092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long acting propranolol in the prophylaxis of migraine. Comparison of the daily doses of 80 mg and 160 mg.
    Havanka-Kanniainen H; Hokkanen E; Myllylä VV
    Headache; 1988 Oct; 28(9):607-11. PubMed ID: 3248938
    [No Abstract]   [Full Text] [Related]  

  • 57. Propranolol in the prophylaxis of migraine.
    Nadelmann JW; Phil M; Stevens J; Saper JR
    Headache; 1986 Apr; 26(4):175-82. PubMed ID: 3519529
    [No Abstract]   [Full Text] [Related]  

  • 58. Propranolol and acetylsalicylic acid in migraine prophylaxis. Double-blind crossover study.
    Baldrati A; Cortelli P; Procaccianti G; Gamberini G; D'Alessandro R; Baruzzi A; Sacquegna T
    Acta Neurol Scand; 1983 Mar; 67(3):181-6. PubMed ID: 6868956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache.
    Sargent J; Solbach P; Damasio H; Baumel B; Corbett J; Eisner L; Jessen B; Kudrow L; Mathew N; Medina J
    Headache; 1985 Sep; 25(6):320-4. PubMed ID: 3902723
    [No Abstract]   [Full Text] [Related]  

  • 60. Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine.
    Verspeelt J; De Locht P; Amery WK
    Cephalalgia; 1996 Aug; 16(5):328-36; discussion 288. PubMed ID: 8869768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.